| Million € | Q1 | ||
|
2020 | 2019 | +/- |
| Sales to third parties | 2,350 | 2,548 | (8%) |
of which Petrochemicals |
1,639 | 1,803 | (9%) |
Intermediates |
711 | 745 | (5%) |
| Income from operations before depreciation, amortization and special items | 391 | 489 | (20%) |
| Income from operations before depreciation and amortization (EBITDA) | 386 | 485 | (20%) |
| EBITDA margin (%) | 16.4 | 19.0 | − |
| Depreciation and amortizationa | 216 | 183 | 18% |
| Income from operations (EBIT) | 170 | 302 | (44%) |
| Special items | (4) | (4) | − |
| EBIT before special items | 174 | 306 | (43%) |
| Assets (March 31) | 9,226 | 9,292 | (1%) |
| Investments including acquisitionsb | 360 | 235 | 53% |
| Research and development expenses | 25 | 27 | (7%) |
a Amortization of intangible assets and depreciation of property, plant and equipment (including impairments and reversals of impairments)
b Additions to intangible assets and property, plant and equipment
| Million € | Q1 | ||
|
2020 | 2019 | +/- |
| Sales to third parties | 2,874 | 2,931 | (2%) |
of which Performance Materials |
1,531 | 1,547 | (1%) |
Monomers |
1,343 | 1,384 | (3%) |
| Income from operations before depreciation, amortization and special items | 415 | 493 | (16%) |
| Income from operations before depreciation and amortization (EBITDA) | 325 | 491 | (34%) |
| EBITDA margin (%) | 11.3 | 16.8 | − |
| Depreciation and amortizationa | 206 | 170 | 21% |
| Income from operations (EBIT) | 119 | 321 | (63%) |
| Special items | (90) | (2) | . |
| EBIT before special items | 209 | 323 | (35%) |
| Assets (March 31) | 10,642 | 9,319 | 14% |
| Investments including acquisitionsb | 1,419 | 134 | . |
| Research and development expenses | 45 | 48 | (6%) |
a Amortization of intangible assets and depreciation of property, plant and equipment (including impairments and reversals of impairments)
b Additions to intangible assets and property, plant and equipment
| Million € | Q1 | ||
|
2020 | 2019 | +/- |
| Sales to third parties | 2,098 | 2,186 | (4%) |
of which Dispersions & Pigments |
1,301 | 1,320 | (1%) |
Performance Chemicals |
797 | 866 | (8%) |
| Income from operations before depreciation, amortization and special items | 343 | 378 | (9%) |
| Income from operations before depreciation and amortization (EBITDA) | 335 | 524 | (36%) |
| EBITDA margin (%) | 16.0 | 24.0 | − |
| Depreciation and amortizationa | 95 | 117 | (19%) |
| Income from operations (EBIT) | 240 | 407 | (41%) |
| Special items | (33) | 143 | . |
| EBIT before special items | 273 | 264 | 3% |
| Assets (March 31) | 7,202 | 7,156 | 1% |
| Investments including acquisitionsb | 67 | 84 | (20%) |
| Research and development expenses | 45 | 49 | (8%) |
a Amortization of intangible assets and depreciation of property, plant and equipment (including impairments and reversals of impairments)
b Additions to intangible assets and property, plant and equipment
| Million € | Q1 | ||
|
2020 | 2019 | +/- |
| Sales to third parties | 4,328 | 3,022 | 43% |
of which Catalysts |
3,532 | 2,118 | 67% |
Coatings |
796 | 904 | (12%) |
| Income from operations before depreciation, amortization and special items | 338 | 255 | 33% |
| Income from operations before depreciation and amortization (EBITDA) | 334 | 252 | 33% |
| EBITDA margin (%) | 7.7 | 8.3 | − |
| Depreciation and amortizationa | 117 | 108 | 8% |
| Income from operations (EBIT) | 217 | 144 | 51% |
| Special items | (3) | (7) | 57% |
| EBIT before special items | 220 | 151 | 46% |
| Assets (March 31) | 12,403 | 11,504 | 8% |
| Investments including acquisitionsb | 83 | 97 | (14%) |
| Research and development expenses | 55 | 50 | 10% |
a Amortization of intangible assets and depreciation of property, plant and equipment (including impairments and reversals of impairments)
b Additions to intangible assets and property, plant and equipment
| Million € | Q1 | ||
|
2020 | 2019 | +/- |
| Sales to third parties | 1,582 | 1,561 | 1% |
of which Care Chemicals |
1,088 | 1,095 | (1%) |
Nutrition & Health |
494 | 466 | 6% |
| Income from operations before depreciation, amortization and special items | 357 | 327 | 9% |
| Income from operations before depreciation and amortization (EBITDA) | 352 | 320 | 10% |
| EBITDA margin (%) | 22.3 | 20.5 | − |
| Depreciation and amortizationa | 108 | 196 | (45%) |
| Income from operations (EBIT) | 244 | 124 | 97% |
| Special items | (10) | (98) | 90% |
| EBIT before special items | 254 | 222 | 14% |
| Assets (March 31) | 6,546 | 6,435 | 2% |
| Investments including acquisitionsb | 102 | 99 | 3% |
| Research and development expenses | 37 | 35 | 6% |
a Amortization of intangible assets and depreciation of property, plant and equipment (including impairments and reversals of impairments)
b Additions to intangible assets and property, plant and equipment
| Million € | Q1 | ||
|
2020 | 2019 | +/- |
| Sales to third parties | 2,819 | 2,649 | 6% |
| Income from operations before depreciation, amortization and special items | 989 | 910 | 9% |
| Income from operations before depreciation and amortization (EBITDA) | 967 | 943 | 3% |
| EBITDA margin (%) | 34.3 | 35.6 | − |
| Depreciation and amortizationa | 180 | 171 | 5% |
| Income from operations (EBIT) | 787 | 772 | 2% |
| Special items | (22) | 32 | . |
| EBIT before special items | 809 | 740 | 9% |
| Assets (March 31) | 17,997 | 18,760 | (4%) |
| Investments including acquisitionsb | 65 | (32) | . |
| Research and development expenses | 207 | 193 | 7% |
a Amortization of intangible assets and depreciation of property, plant and equipment (including impairments and reversals of impairments)
b Additions to intangible assets and property, plant and equipment
| Million € | Q1 | ||
| 2020 | 2019 | +/- |
|
| Sales | 702 | 699 | 0% |
| Income from operations before depreciation, amortization and special itemsa | (254) | (210) | (21%) |
| Income from operations before depreciation and amortization (EBITDA)a | (271) | (245) | (11%) |
| Depreciation and amortizationb | 50 | 46 | 9% |
| Income from operations (EBIT)a | (321) | (291) | (10%) |
| Special itemsa | (22) | (35) | 37% |
| EBIT before special itemsa | (299) | (256) | (17%) |
of which costs for cross-divisional corporate research |
(75) | (98) | 23% |
costs of corporate headquarters |
(54) | (58) | 7% |
other businesses |
27 | 37 | (27%) |
foreign currency results, hedging and other measurement effects |
52 | (25) | . |
miscellaneous income and expenses |
(249) | (112) | . |
| Assets (March 31)c | 28,339 | 29,574 | (4%) |
| Investments including acquisitionsd | 40 | 98 | (59%) |
| Research and development expenses | 80 | 101 | (21%) |
a The 2019 figures have been restated to reflect the reclassification of income from non-integral companies accounted for using the equity method to net income from shareholdings. For more information, see Significant Events.
b Amortization of intangible assets and depreciation of property, plant and equipment (including impairments and reversals of impairments)
c Contains assets of businesses recognized under Other as well as reconciliation to assets of the BASF Group
d Additions to intangible assets and property, plant and equipment
| Million € | Sales Location of company |
Sales Location of customer |
Income from operations Location of company |
||||||
Q1 |
2020 |
2019 |
+/– |
2020 |
2019 |
+/– |
2020 |
2019 |
+/– |
| Europe | 7,520 | 7,188 | 5% | 7,211 | 6,673 | 8% | 681 | 850 | (20%) |
of which Germany |
3,273 | 3,988 | (18%) | 1,688 | 1,603 | 5% | 198 | 406 | (51%) |
| North America | 5,246 | 4,641 | 13% | 4,985 | 4,544 | 10% | 474 | 647 | (27%) |
| Asia Pacific | 3,295 | 3,098 | 6% | 3,473 | 3,320 | 5% | 286 | 278 | 3% |
| South America, Africa, Middle East | 692 | 669 | 3% | 1,084 | 1,059 | 2% | 15 | 4 | 275% |
| BASF Group | 16,753 | 15,596 | 7% | 16,753 | 15,596 | 7% | 1,456 | 1,779 | (18%) |
a The 2019 figures have been restated to reflect the reclassification of income from non-integral companies accounted for using the equity method to net income from shareholdings. For more information, see Significant Events.